Biotech Values

[mcbio]

VRUS is lucky I'm not CFO aside from being highly unqualified for the position I would've diluted like crazy quite some time ago .

LOL And VRUS would be crazy not to dilute now. The stock has had a hell of a run and I really think they should use the run to their advantage and do a nice offering here. They'd be in a great position if they did so.

I actually enjoy listening to Price talk he sounds all gung ho but something bothers me a bit about this company and I can't quite put my finger on it.

It's been awhile since I've listened to one of their presentations but I agree in that I do recall enjoying listening to Price's presentations. I think VRUS is in a great position. Given IDIX's issues with the clinical hold, you have to think they are absolutely in the lead now for partnering a 2nd/3rd gen HCV nuke and otherwise the dominant company in the HCV nuke space. And given that nukes are projected to form the backbone of HCV therapy in the future, that's quite a position to be in. The question is always, what's the right value for the stock given where they are? I just am never comfortable chasing a stock that has had a hell of a run and they do now sport about a $1.6B market cap. But, if you compare it to where VRTX is now at an almost $7B market cap, it doesn't sound so unreasonable. I honestly don't know what to think about the stock. I still question why Roche hasn't already partnered with them for their follow-on nukes, if not otherwise bought VRUS out. Perhaps one of those events is coming soon or is there something else at play? I don't know. If they did a real nice offering, I know I would be more inclined to consider VRUS. ; )